Miami, Florida 33136


Purpose:

Basal-bolus insulin therapy, which includes one injection of long acting insulin and three injections of short acting insulin is the most commonly used insulin treatment. However, many older patients find the basal-bolus insulin regimen hard to manage because it involves 4 injections and 4 blood glucose tests each day. It is possible that a simplified treatment that involves one injection of long acting insulin daily and two blood glucose tests daily might be equally effective. This simplified regimen, if effective, would be easier to use and might result in less errors. Therefore, the investigators want to conduct this study to compare using a single daily injection of basal insulin with the usual basal-bolus insulin regimen in elderly patients (age >65 years) with type 2 diabetes.


Criteria:

Inclusion Criteria: - Age >65 years - Patient treated with an insulin regimen for at least 3 months - HbA1c >8% at the time of enrollment Exclusion Criteria: - Unable to provide informed consent - Enrollment in another research study - History of hypoglycemia unawareness - Pregnant women - Prisoners


NCT ID:

NCT03660553


Primary Contact:

Principal Investigator
Rajesh Garg, MD
University of Miami

Rajesh Garg, MD
Phone: 3056890257
Email: rgarg@miami.edu


Backup Contact:

N/A


Location Contact:

Miami, Florida 33136
United States

Rajesh Garg, MD
Phone: 305-689-0257
Email: rgarg@miami.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.